Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Nature Structural Biology · 01.04.2002 · 9 (4) · 268-272
DOI: 10.1038/nsb770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Structural Biology, online erschienen am 18.03.2002. Verfasst von Christopher Pargellis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Boehringer Ingelheim Pharmaceuticals, Research and Development Center, 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA.…. Die Arbeit wurde bisher 761-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Boehringer Ingelheim Pharmaceuticals, Research and Development Center, 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA. cpargel@rdg.boehringer-ingelheim.com
Zitieren
APA
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., & Regan, J. (2002). Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature Structural Biology, 9(4), 268-272. https://doi.org/10.1038/nsb770
Vancouver
Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature Structural Biology. 2002;9(4):268-272. doi:10.1038/nsb770
BibTeX
@article{Pargellis2002,
author = {Pargellis, Christopher and Tong, Liang and Churchill, Laurie and Cirillo, Pier F and Gilmore, Thomas and Graham, Anne G and Grob, Peter M and Hickey, Eugene R and Moss, Neil and Pav, Susan and Regan, John},
title = {Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site},
journal = {Nature Structural Biology},
year = {2002},
volume = {9},
number = {4},
pages = {268--272},
doi = {10.1038/nsb770}
}
EUVIMED